School personnel information

写真b

SHIMA Yoshihito


Keyword

systemic sclerosis, scleroderma

Mail Address

Mail Address

Laboratory Phone number

+81-6-6879-3833

Laboratory Fax number

+81-6-6879-3839

URL

http://www.med.osaka-u.ac.jp/pub/imed3/lab_2/

Gender

Male

Organization 【 display / non-display

  • 2003.04.01 - 2007.03.31, Division of Internal Medicine, Graduate School of Medicine, Research Assistant

  • 2007.04.01 - 2010.09.30, Division of Internal Medicine, Graduate School of Medicine, Assistant Professor

  • 2010.10.01 - 2015.04.30, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2015.05.01 - 2018.03.31, Division of Medicine, Graduate School of Medicine, Associate Professor

  • 2018.04.01 - , Graduate School of Medicine, Specially Appointed Professor

Employment Record 【 display / non-display

Assistant professor of Respiratory medicine, Allergy and Rheumatic diseases, Osaka university graduate school of medicine 2007.04 - 2015.03
Assistant professor of Respratory medicine and Clinical immunology, Osaka university graduate school of medicine 2015.05 - 2018.03
Professor of Thermo-therapeutics for vasucular dysfunctoin, Osaka university graduate school of medicine 2018.04 -

Research topics 【 display / non-display

  • Verification of the therapeutic effect of Raynaud's phenomenon using hyperthermia on patients with systemic sclerosis (scleroderma)
    General internal medicine-related

  • The study of clinical effect of interleukin-6 blockage in the patient with systemic sclerosis
    Connective tissue disease and allergy-related

  • The measurement of phisical properties of scleroderma skin
    Connective tissue disease and allergy-related

  • Anti-inflammatory effect of retinoids
    Connective tissue disease and allergy-related

Academic Society Membership 【 display / non-display

  • The Japanese Association for Infectious Diseases

 

Academic Papers 【 display / non-display

  • Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy., Shima Y, Kawaguchi Y, Kuwana M, Modern Rheumatology,29、1,134-139, 2019.01, Papers

  • Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis., Morita T, Shima Y, Fujimoto K, Tsuboi H, Saeki Y, Narazaki M, Ogata A, Kumanogoh A, International immunology,Volume 31, Issue 5, Page 277-285, 2019.04, Papers

  • The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis., Shima Y, Modern Rheumatology,29(2), 2019.03, Review Papers

  • Anti-receptor activator of nuclear factor kappa-B ligand antibody treatment increases osteoclastogenesis-promoting interleukin-8 in patients with rheumatoid arthritis., Morita T, Shima Y, Fujimoto K, Tsuboi H, Saeki Y, Narazaki M, Ogata A, Kumanogoh A., International Immunology,in press, 2019.02, Papers

  • Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy., Shima Y, Kawaguchi Y, Kuwana M., Modern Rheumatology,29(1), 2019.01, Papers

display all >>

Books 【 display / non-display

  • Special, Systemic Sclerosis, Yoshihito Shima, Springer, ISBN, 978-4-431-55708-1, 2016.02

  • Special, Therapeutic potentials of IL-6 inhibition for systemic sclerosis., 2. Shima Y, Kuwana M., Future Medicin, 2013.04

  • Special, Flavonoids, Natural inhibitors of basophil activation. Chapter 4, in Basophil Granulocytes,, T. Tanaka, T. Hirano, M. Kawai, J. Arimitsu, K. Hagihara, M. Ogawa, Y. Kuwahara, Y. Shima, M. Narazaki, A. Ogata, I. Kawase, Nova Science Publishers Inc., ISBN, 9781607417972, 2011.03

 

Lecture / Exhibition 【 display / non-display

  • Lupus Manegement Forum in Tohoku, 2017.09